{
  "abstract": "A trial of lenacapavir showed 100% protection against HIV infection. But cuts to foreign aid and criticism over its pricing put the brakes on a worldwide rollout. Elna Schütz asks if we’re now seeing the reprieve that advocates were hoping for",
  "authors": [
    {
      "affiliations": [
        "Johannesburg"
      ],
      "name": "Elna Schütz"
    }
  ],
  "title": "“Miraculous” HIV drug to be rolled out after overcoming aid cuts threat",
  "uid": "cbb651cf-7dff-5145-a8e2-16aa22325312"
}